{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:08:23Z","timestamp":1777396103362,"version":"3.51.4"},"reference-count":40,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2023,5,2]]},"abstract":"<jats:p>Background: Clearance of tau seeds by immunization with tau antibodies is currently evaluated as therapeutic strategy to block the spreading of tau pathology in Alzheimer\u2019s disease and other tauopathies. Preclinical evaluation of passive immunotherapy is performed in different cellular culture systems and in wild-type and human tau transgenic mouse models. Depending on the preclinical model used, tau seeds or induced aggregates can either be of mouse, human or mixed origin. Objective: We aimed to develop human and mouse tau-specific antibodies to discriminate between the endogenous tau and the introduced form in preclinical models. Methods: Using hybridoma technology, we developed human and mouse tau-specific antibodies that were then used to develop several assays to specifically detect mouse tau. Results: Four antibodies, mTau3, mTau5, mTau8, and mTau9, with a high degree of specificity for mouse tau were identified. Additionally, their potential application in highly sensitive immunoassays to measure tau in mouse brain homogenate and cerebrospinal fluid is illustrated, as well as their application for specific endogenous mouse tau aggregation detection. Conclusion: The antibodies reported here can be very important tools to better interpret the results obtained from different model systems as well as to study the role of endogenous tau in tau aggregation and pathology observed in the diverse mouse models available.<\/jats:p>","DOI":"10.3233\/jad-221266","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T12:25:13Z","timestamp":1679401513000},"page":"151-167","source":"Crossref","is-referenced-by-count":1,"title":["Development and Characterization of Mouse-Specific Anti-Tau Monoclonal Antibodies: Relevance for Analysis of Murine Tau in Cerebrospinal Fluid"],"prefix":"10.1177","volume":"93","author":[{"given":"Dina","family":"Rodrigues Martins","sequence":"first","affiliation":[{"name":"Neuroscience Department, Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Vandermeeren","sequence":"additional","affiliation":[{"name":"Neuroscience Department, Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristof","family":"Van Kolen","sequence":"additional","affiliation":[{"name":"Neuroscience Department, Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eddy","family":"Brepoels","sequence":"additional","affiliation":[{"name":"Biologics Research, Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Borgers","sequence":"additional","affiliation":[{"name":"Neuroscience Department, Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"Wintmolders","sequence":"additional","affiliation":[{"name":"Neuroscience Department, Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Delay","sequence":"additional","affiliation":[{"name":"Neuroscience Department, Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Bottelbergs","sequence":"additional","affiliation":[{"name":"Neuroscience Department, Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Mercken","sequence":"additional","affiliation":[{"name":"Neuroscience Department, Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Theunis","sequence":"additional","affiliation":[{"name":"Neuroscience Department, Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-221266_ref1","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1083\/jcb.101.4.1371","article-title":"The distribution of tau in the mammalian central nervous system","volume":"101","author":"Binder","year":"1985","journal-title":"J Cell Biol"},{"key":"10.3233\/JAD-221266_ref2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","article-title":"Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer\u2019s disease","volume":"3","author":"Goedert","year":"1989","journal-title":"Neuron"},{"key":"10.3233\/JAD-221266_ref3","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1083\/jcb.103.6.2739","article-title":"Tau protein function in living cells","volume":"103","author":"Drubin","year":"1986","journal-title":"J Cell Biol"},{"key":"10.3233\/JAD-221266_ref4","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1097\/00001756-199708180-00029","article-title":"Somatodendritic localization of phosphorylated tau in neonatal and adult rat cerebral cortex","volume":"8","author":"Tashiro","year":"1997","journal-title":"Neuroreport"},{"key":"10.3233\/JAD-221266_ref5","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1074\/jbc.M110.199976","article-title":"Nuclear tau, a key player in neuronal DNA protection","volume":"286","author":"Sultan","year":"2011","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-221266_ref6","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.15252\/embj.201593518","article-title":"Novel function of tau in regulating the effects of external stimuli on adult hippocampal neurogenesis","volume":"35","author":"Pallas-Bazarra","year":"2016","journal-title":"EMBO J"},{"key":"10.3233\/JAD-221266_ref7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","article-title":"Roles of tau protein in health and disease","volume":"133","author":"Guo","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-221266_ref8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.brainresbull.2016.08.018","article-title":"Tau and tauopathies","volume":"126","author":"Arendt","year":"2016","journal-title":"Brain Res Bull"},{"key":"10.3233\/JAD-221266_ref9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.410400204","article-title":"Neurodegenerative disorders with extensive tau pathology: A comparative study and review","volume":"40","author":"Feany","year":"1996","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-221266_ref10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-221266_ref11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: A review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-221266_ref12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13024-017-0231-7","article-title":"Practical considerations for choosing a mouse model of Alzheimer\u2019s disease","volume":"12","author":"Jankowsky","year":"2017","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-221266_ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2015.12.003","article-title":"Toward more predictive genetic mouse models of Alzheimer\u2019s disease","volume":"122","author":"Onos","year":"2016","journal-title":"Brain Res Bull"},{"key":"10.3233\/JAD-221266_ref14","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s00335-001-2044-8","article-title":"A genomic sequence analysis of the mouse and human microtubule-associated protein tau","volume":"12","author":"Poorkaj","year":"2001","journal-title":"Mamm Genome"},{"key":"10.3233\/JAD-221266_ref15","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.1073\/pnas.1301175110","article-title":"Brain homogenates from human tauopathies induce tau inclusions in mouse brain","volume":"110","author":"Clavaguera","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-221266_ref16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nbd.2014.08.032","article-title":"Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice","volume":"73","author":"Peeraer","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-221266_ref17","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1084\/jem.20160833","article-title":"Unique pathological tau conformers from Alzheimer\u2019s brains transmit tau pathology in nontransgenic mice","volume":"213","author":"Guo","year":"2016","journal-title":"J Exp Med"},{"key":"10.3233\/JAD-221266_ref18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3233\/JAD-180404","article-title":"Anti-tau monoclonal antibodies derived from soluble and filamentous tau show diverse functional properties in vitro and in vivo","volume":"65","author":"Vandermeeren","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-221266_ref19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.3233\/JAD-221266_ref20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature"},{"key":"10.3233\/JAD-221266_ref21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jmr.846","article-title":"Functional reconstruction and synthetic mimicry of a conformational epitope using CLIPSTM technology","volume":"20","author":"Timmerman","year":"2007","journal-title":"J Mol Recognit"},{"key":"10.3233\/JAD-221266_ref22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ab.2011.06.002","article-title":"Helical peptide arrays for lead identification and interaction site mapping","volume":"417","author":"Langedijk","year":"2011","journal-title":"Anal Biochem"},{"key":"10.3233\/JAD-221266_ref23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/82868","article-title":"Neurotrophins are required for nerve growth during development","volume":"4","author":"Tucker","year":"2001","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-221266_ref24","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1074\/jbc.M409876200","article-title":"Changed conformation of mutant tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of tau-4R\/2N transgenic mice","volume":"280","author":"Terwel","year":"2005","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-221266_ref26","doi-asserted-by":"crossref","first-page":"100636","DOI":"10.1016\/j.jbc.2021.100636","article-title":"PIKfyve activity is required for lysosomal trafficking of tau aggregates and tau seeding","volume":"296","author":"Soares","year":"2021","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-221266_ref27","doi-asserted-by":"crossref","first-page":"9340","DOI":"10.1523\/JNEUROSCI.22-21-09340.2002","article-title":"Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein","volume":"22","author":"Allen","year":"2002","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-221266_ref28","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1471-4159.2003.01879.x","article-title":"Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms","volume":"86","author":"Andorfer","year":"2003","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-221266_ref29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3233\/JAD-130986","article-title":"Endogenous tau aggregates in oligodendrocytes of rTg4510 mice induced by human P301L tau","volume":"38","author":"Ren","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-221266_ref30","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1523\/JNEUROSCI.0587-07.2007","article-title":"Accumulation of pathological tau species and memory loss in a conditional model of tauopathy","volume":"27","author":"Berger","year":"2007","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-221266_ref31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF00227819","article-title":"Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes","volume":"84","author":"Mercken","year":"1992","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-221266_ref32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/prot.24988","article-title":"Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti-tau antibody AT8","volume":"84","author":"Malia","year":"2016","journal-title":"Proteins"},{"key":"10.3233\/JAD-221266_ref33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3233\/JAD-2012-121093","article-title":"Characteristics of TBS-extractable hyperphosphorylated tau species: Aggregation intermediates in rTg4510 mouse brain","volume":"33","author":"Sahara","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-221266_ref34","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nbt.1641","article-title":"Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations","volume":"28","author":"Rissin","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.3233\/JAD-221266_ref35","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/2211068215589580","article-title":"The Simoa HD-1 analyzer: A novel fully automated digital immunoassay analyzer with single-molecule sensitivity and multiplexing","volume":"21","author":"Wilson","year":"2016","journal-title":"J Lab Autom"},{"key":"10.3233\/JAD-221266_ref36","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/ene.13389","article-title":"Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: A neuropathology-based cohort. ,","volume":"24","author":"Kovacs","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-221266_ref37","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/jnnp-2017-317260","article-title":"Plasma tau is increased in frontotemporal dementia","volume":"89","author":"Foiani","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-221266_ref38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.dadm.2019.05.001","article-title":"Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer\u2019s disease","volume":"11","author":"Fossati","year":"2019","journal-title":"Alzheimers Dementia (Amst)"},{"key":"10.3233\/JAD-221266_ref39","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1042\/BST0381001","article-title":"Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model","volume":"38","author":"Heraud","year":"2010","journal-title":"Biochem Soc Trans"},{"key":"10.3233\/JAD-221266_ref40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.nbd.2013.10.019","article-title":"Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition","volume":"62","author":"LaFerla","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-221266_ref41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000283479","article-title":"\u201cPrion-like\u201d propagation of mouse and human tau aggregated in an inducible mouse model of tauopathy","volume":"7","author":"Sydow","year":"2010","journal-title":"Neurodegener Dis"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-221266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:33Z","timestamp":1777370853000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-221266"}},"subtitle":[],"editor":[{"given":"Peppino","family":"Mirabelli","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":40,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-221266","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]}}}